Authors


Kenneth J. Sklar, EdD

Latest:

Assessing Outcomes in Child Psychiatry

Two standardized rating scales appeared to be valid and reliable for use at admission and possibly follow-up in a child psychiatry system of care.













Piia T. Lavikainen, MSc

Latest:

Pattern of Statin Use Among 10 Cohorts of New Users From 1995 to 2004: A Register-Based Nationwide Study

One-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.





Robert Wellman, MS

Latest:

Decision Aids for Benign Prostatic Hyperplasia and Prostate Cancer

Implementing patient decision aids was associated with lower rates of elective surgery for benign prostatic hyperplasia and of active treatment for localized prostate cancer.


Anna D. Coutinho, PhD

Latest:

Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMIT

This cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.





Mark Holmes, PhD

Latest:

The Effect of Narrow Network Plans on Out-of-Pocket Cost

The authors examined the effect of narrow network plan selection on beneficiaries’ outpatient visits and outpatient out-of-pocket expenditures in the 2014 nongroup health insurance market.



Fengming Tang, MS

Latest:

Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events

Use of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.


Alfred Lewis, JD

Latest:

Employers Should Disband Employee Weight Control Programs

No corporate weight control program has ever reported savings or even sustained weight loss using valid metrics across a sizable population for 2 years or more, accounting for dropouts and nonparticipants. Further, these programs can harm morale and even the health of the employees themselves.


Steven M. Asch, MD

Latest:

Beyond Satisfaction Scores: Exploring Emotionally Adverse Patient Experiences

This study explores the causes of emotionally adverse patient experiences in cancer care and presents a taxonomy for analyzing free-text patient data.


Brett Fortune, MD, MSc

Latest:

Inflammatory Bowel Disease Readmissions Are Associated With Utilization and Comorbidity

Thirty-day readmissions related to inflammatory bowel disease are common and associated with longer length of stay and a higher likelihood of having an associated comorbid condition compared with index hospitalizations.


Marc Pawels, Dipl-Psych

Latest:

Identifying Groups of Nonparticipants in Type 2 Diabetes Mellitus Education

This study describes reasons for nonparticipation in type 2 diabetes mellitus education and identifies typical subgroups of nonparticipants in order to improve recruitment strategies.


Stephen E. Asche, MA

Latest:

It Is Time to Ask Patients What Outcomes Are Important to Them

Patients with abdominal or back pain identified 21 outcomes important to them, but the reported outcomes are quite different from the symptom and function outcomes studied by researchers.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo